| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,500,000 |
| Market
Cap: |
1.95(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$35.77 - $65 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
32,136 |
465,065 |
655,744 |
1,062,982 |
| Total Sell Value |
$1,503,716 |
$26,033,932 |
$35,438,128 |
$50,015,597 |
| Total People Sold |
3 |
7 |
9 |
11 |
| Total Sell Transactions |
5 |
17 |
34 |
71 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zhou Rong |
EVP, Production Center |
• – – |
2023-03-16 |
4 |
D |
$37.60 |
$85,841 |
D/D |
(2,283) |
89,499 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-16 |
4 |
D |
$37.60 |
$187,812 |
D/D |
(4,995) |
109,310 |
|
- |
|
| Luo Mary Z. |
COO,Chief Scientist & Chairman |
• • • |
2023-03-16 |
4 |
D |
$37.60 |
$375,925 |
I/I |
(9,998) |
1,462,654 |
|
- |
|
| Luo Mary Z. |
COO,Chief Scientist & Chairman |
• • • |
2023-03-16 |
4 |
D |
$37.60 |
$949,062 |
D/D |
(25,241) |
2,094,486 |
|
- |
|
| Luo Mary Z. |
COO,Chief Scientist & Chairman |
• • • |
2023-03-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
114,730 |
0 |
|
- |
|
| Luo Mary Z. |
COO, Chief Sci. and Chairman |
• • • |
2023-03-15 |
4 |
D |
$36.84 |
$103,263 |
I/I |
(2,803) |
1,530,017 |
|
- |
|
| Luo Mary Z. |
COO, Chief Sci. and Chairman |
• • • |
2023-03-15 |
4 |
D |
$36.84 |
$310,709 |
D/D |
(8,434) |
2,177,092 |
|
- |
|
| Liawatidewi Yakob |
EVP Corp Admin Center |
• – – |
2023-03-15 |
4 |
D |
$36.84 |
$68,191 |
D/D |
(1,851) |
72,508 |
|
- |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2023-03-15 |
4 |
D |
$36.84 |
$75,780 |
D/D |
(2,057) |
91,782 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-15 |
4 |
D |
$36.84 |
$152,739 |
D/D |
(4,146) |
114,305 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-15 |
4 |
AS |
$36.43 |
$465,472 |
D/D |
(12,776) |
118,451 |
|
67% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-15 |
4 |
OE |
$14.95 |
$99,986 |
D/D |
6,688 |
131,227 |
|
- |
|
| Liawatidewi Yakob |
EVP Corp Admin Center |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,752 |
74,359 |
|
- |
|
| Luo Mary Z. |
CEO & Chief Scientific Officer |
• • • |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
34,301 |
1,532,820 |
|
- |
|
| Luo Mary Z. |
CEO & Chief Scientific Officer |
• • • |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
81,383 |
2,185,526 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,925 |
124,539 |
|
- |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,129 |
93,839 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-01 |
4 |
AS |
$36.33 |
$398,685 |
D/D |
(10,974) |
100,614 |
|
51% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2023-03-01 |
4 |
OE |
$11.33 |
$124,335 |
D/D |
10,974 |
111,588 |
|
- |
|
| Petersen Floyd F. |
Director |
– • – |
2023-03-01 |
4 |
AS |
$33.70 |
$18,349 |
D/D |
(500) |
85,608 |
|
51% |
|
| Petersen Floyd F. |
Director |
– • – |
2023-02-01 |
4 |
AS |
$30.35 |
$15,176 |
D/D |
(500) |
86,108 |
|
54% |
|
| Petersen Floyd F. |
Director |
– • – |
2023-01-03 |
4 |
AS |
$27.94 |
$13,971 |
D/D |
(500) |
86,608 |
|
48% |
|
| Petersen Floyd F. |
Director |
– • – |
2022-12-01 |
4 |
AS |
$30.13 |
$15,067 |
D/D |
(500) |
87,108 |
|
39% |
|
| Petersen Floyd F. |
Director |
– • – |
2022-11-01 |
4 |
AS |
$31.13 |
$15,565 |
D/D |
(500) |
87,608 |
|
18% |
|
| Petersen Floyd F. |
Director |
– • – |
2022-10-03 |
4 |
AS |
$28.59 |
$14,296 |
D/D |
(500) |
88,108 |
|
14% |
|
954 Records found
|
|
Page 5 of 39 |
|
|
0.28 (0.69%) 
